MedPath
HSA Approval

LEVORES SOLUTION FOR INFUSION 5MG/ML

SIN16966P

LEVORES SOLUTION FOR INFUSION 5MG/ML

LEVORES SOLUTION FOR INFUSION 5MG/ML

March 4, 2024

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

GOLDPLUS UNIVERSAL PTE LTD

Therapeutic

Prescription Only

Formulation Information

INFUSION, SOLUTION

INTRAVENOUS

Medical Information

J01MA12

levofloxacin

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

PT. Novell Pharmaceutical Laboratories

Active Ingredients

Levofloxacin Hemihydrate eqv Levofloxacin

5mg/ml

Levofloxacin

Documents

Package Inserts

Levores Solution for Infusion PI.pdf.pdf

Approved: March 4, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LEVORES SOLUTION FOR INFUSION 5MG/ML - HSA Approval | MedPath